Publications by authors named "Mario Bigioni"

Claim this Profile
T
The Dual PIM/FLT3 Inhibitor MEN1703 Combines Synergistically With Gilteritinib in FLT3-ITD-Mutant Acute Myeloid Leukaemia.
Sonia Zicari, Giuseppe Merlino, Alessandro Paoli, Alessio Fiascarelli, Patrizia Tunici, Mario Bigioni

J Cell Mol Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway.
Giuliana Papoff, Dario Presutti, Valentina Fustaino, Andrea Parente, Clelia Calandriello, Mario Bigioni

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer.
Alessio Fiascarelli, Giuseppe Merlino, Stefania Capano, Simone Talucci, Diego Bisignano, Mario Bigioni

Breast Cancer Res Treat· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models.
Eugenio Gaudio, Chiara Tarantelli, Filippo Spriano, Francesca Guidetti, Giulio Sartori, Mario Bigioni

Haematologica· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors.
Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, Alessandro Bressan, Corrado Carrisi

Mol Cancer Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 2: 7-fluorobenzothiophenes and benzofurans.
Elena Marastoni, Sandra Bartoli, Marco Berettoni, Amalia Cipollone, Alessandro Ettorre, Mario Bigioni

Bioorg Med Chem Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.
Tommaso Colangelo, Alessandra Fucci, Carolina Votino, Lina Sabatino, Massimo Pancione, Mario Bigioni

Neoplasia· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 1: hit identification.
Elena Marastoni, Sandra Bartoli, Marco Berettoni, Amalia Cipollone, Alessandro Ettorre, Mario Bigioni

Bioorg Med Chem Lett· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line.
Daniela Bellarosa, Alessandro Bressan, Mario Bigioni, Massimo Parlani, Carlo Alberto Maggi

Int J Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures.
Mario Bigioni, Alessandro Ettorre, Patrizia Felicetti, Sandro Mauro, Cristina Rossi

Bioorg Med Chem Lett· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of rebeccamycin analogues modified at the imide moiety.
Fabio Animati, Marco Berettoni, Mario Bigioni, Monica Binaschi, Amalia Cipollone

Bioorg Med Chem Lett· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors.
Cristina Rossi, Christopher I Fincham, Piero D'Andrea, Marina Porcelloni, Alessandro Ettorre, Mario Bigioni

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined antihypertensive and cardioprotective effects of nebivolol and hydrochlorothiazide in spontaneous hypertensive rats.
Giuseppe Sacco, Stefano Evangelista, Stefano Manzini, Massimo Parlani, Mario Bigioni

Future Cardiol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors.
Cristina Rossi, Marina Porcelloni, Piero D'Andrea, Christopher I Fincham, Alessandro Ettorre, Mario Bigioni

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance therapy in ovarian cancer: Molecular basis and therapeutic approach.
Monica Binaschi, Cecilia Simonelli, Cristina Goso, Mario Bigioni, Carlo Alberto Maggi

Exp Ther Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of a less aggressive phenotype in human colon carcinoma HCT116 cells by chronic exposure to HDAC inhibitor SAHA.
Alessandro Bressan, Mario Bigioni, Daniela Bellarosa, Federica Nardelli, Clelia Irrissuto

Oncol Rep· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative and differentiating activities of a novel series of histone deacetylase inhibitors.
Monica Binaschi, Andrea Boldetti, Maurizio Gianni, Carlo Alberto Maggi, Martina Gensini, Mario Bigioni

ACS Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of delimotecan against human metastatic melanoma: pharmacokinetics and molecular determinants.
Mario Bigioni, Massimo Parlani, Alessandro Bressan, Daniela Bellarosa, Licia Rivoltini

Int J Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Giuseppe Sacco, Bigioni Mario, Giuseppe Lopez, Stefano Evangelista, Stefano Manzini

Vascul Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation, and molecular modeling studies of rebeccamycin analogues modified in the carbohydrate moiety.
Fabio Animati, Marco Berettoni, Mario Bigioni, Monica Binaschi, Patrizia Felicetti

ChemMedChem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sabarubicin (MEN10755)-induced apoptosis is independent from mtDNA in A2780 human ovarian tumor cells.
Alessandro Bressan, Federica Nardelli, Daniela Bellarosa, Mario Bigioni, Giuseppe Curcurù

Anticancer Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels.
Laura Di Renzo, Mario Bigioni, Vera Del Gobbo, Maria Grazia Premrov, Ugo Barbini

Pharmacol Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal-weight obese syndrome: early inflammation?
Antonino De Lorenzo, Vera Del Gobbo, Maria Grazia Premrov, Mario Bigioni, Fabio Galvano

Am J Clin Nutr· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human and murine macrophages mediate activation of MEN 4901/T-0128: a new promising camptothecin analogue-polysaccharide conjugate.
Monica Binaschi, Massimo Parlani, Daniela Bellarosa, Mario Bigioni, Carmela Salvatore

Anticancer Drugs· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231.
Mario Bigioni, Alfredina Benzo, Clelia Irrissuto, Carlo Alberto Maggi, Cristina Goso

Anticancer Drugs· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis